Bookmark

Add to MyYahoo RSS

Dey News

News on Dey (Ticker: MYL) continually updated from thousands of sources around the net.

Thursday | BioSpace

Mylan Inc.'s ANDA For Three Times Per Week Generic Copaxone?? 40 Mg/Ml Accepted For Filing By FDA

Mylan Inc. 's ANDA For Three Times Per Week Generic CopaxoneA 40 Mg/Ml Accepted For Filing By FDA /PRNewswire/ -- Mylan Inc. today announced that its abbreviated new drug application for a three times per week Glatiramer Acetate Injection 40 mg/mL has been accepted for filing by the U.S. Food and Drug Administration .

Comment?

Related Topix: Food and Drug Administration, Biotech, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry, Startups, Marketing

Wed Aug 27, 2014

Seeking Alpha

Mylan: Deeply Undervalued On Unwarranted Approval Concerns

Mylan is a manufacturer of generic pharmaceuticals. It closed on Tuesday, August 25, 2014 at $48.30.

Comment?

Related Topix: Biotech, Startups, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry

Mon Aug 25, 2014

Freshnews

Ready2Go(TM) Draft Winners Join Pro Football MVP Adrian Peterson in...

Mylan Specialty, the fully integrated specialty pharmaceutical business of Mylan Inc. , and pro football player and EpiPen Auto-Injector spokesperson Adrian Peterson today announced the three winners of the Ready2Go MVP Draft , a nationwide search to find kids who have potentially life-threatening allergies and are prepared to respond should a ... (more)

Comment?

Related Topix: Epinephrine (generic), Epipen, Medicine, Biotech, Pharmaceuticals, Mylan Laboratories, Healthcare Industry, Startups, Family, Kids, Frisco, TX, Hives, Health

Seeking Alpha

Apricus Biosciences: A Screaming Buy Or A Falling Knife?

The company has fallen 20% since the first launch even though the short rate has also fallen, indicating investors are just walking away.

Comment?

Related Topix: NexMed, Biotech, Medicine, Healthcare Industry, Pharmaceuticals, Mylan Laboratories, Startups

Fri Aug 22, 2014

Post-gazette.com

Business Forum: The problem or a symptom?

The Obama administration urged lawmakers recently to pass legislation to contain the number of companies reincorporating overseas for tax purposes, commonly referred to as corporate inversion.

Comment?

Related Topix: Biotech, Startups, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry, Opinion

Sys-Con Media

Mylan Launches First Generic Klor-ConA Extended-Release Tablets

Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product, which is indicated for the treatment of patients with hypokalemia, with or without metabolic alkalosis; in digitalis intoxication; and in patients with hypokalemic familial periodic paralysis.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry, Startups, Chloride, Supplement, Food and Drug Administration

Wed Aug 20, 2014

Sys-Con Media

New Drug Launches, Technical Updates, New Facility, Clinical Trials...

Today, Analysts Review released its research reports regarding Covidien PLC , Mylan, Inc. , Baxter International Inc. , Achillion Pharmaceuticals, Inc. and Perrigo Company PLC .

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry, Startups, Manufacturing, Industrial Machines, Foley, Covidien, VNUS Medical Technologies

Tue Aug 19, 2014

Sys-Con Media

Mylan Launches Generic Precedexa Injection - Another Key Product Approval

Mylan yesterday received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for this product, which is indicated for the sedation of non-intubated patients prior to and/or during surgical and other procedures, and began shipping immediately.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry, Startups, Food and Drug Administration

Mon Aug 11, 2014

Medical News

Mylan announces launch of Capecitabine Tablets USP, 150 mg and 500 mg

Mylan Inc. today announced that it has launched Capecitabine Tablets USP, 150 mg and 500 mg, the generic version of Genentech's Xeloda Tablets.

Comment?

Related Topix: Biotech, Medicine, Xeloda, Capecitabine (generic), Pharmaceuticals, Mylan Laboratories, Healthcare Industry, Startups, Food and Drug Administration, Health

Seeking Alpha

The Long Case For Mylan

After declining 20% from all-time highs in February, analysts are finally chasing Mylan by downgrading price targets for the year, which has proven to be a classic contrarian indicator.

Comment?

Related Topix: Biotech, Startups, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry

Fri Aug 08, 2014

MarketNewsVideo

Nasdaq 100 Movers: MYL, NVDA

In early trading on Friday, shares of NVIDIA topped the list of the day's best performing components of the Nasdaq 100 index, trading up 7.2%.

Comment?

Related Topix: Startups, NVidia, mental images, Biotech, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry, Business News, Video

AmericanBankingNews.com

RBC Capital Downgrades Mylan to Sector Perform

Mylan opened at 46.49 on Friday. Mylan has a 52 week low of $34.46 and a 52 week high of $57.52.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry, Startups

Thu Aug 07, 2014

Investor's Business Daily

Novo Nordisk, Mylan Miss Views; Mallinckrodt Beats

Earnings reports from specialty drugmakers continued to roll in Thursday, as two leading stocks stumbled in the early going on the stock market today .

Comment?

Related Topix: Biotech, Startups, Medicine, Pharmaceuticals, Mylan Laboratories, Novo Nordisk AS, Healthcare Industry, Financial Markets, Healthcare Law, Law, Food and Drug Administration

Value Line

Stock Market Today: August 7, 2014

Stocks to Watch from The Survey : Today is set to be another busy day on Wall Street, with investors digesting a slew of earnings reports.

Comment?

Related Topix: Financial Markets, Beverages, Food, Green Mountain Coffee Roasters, Startups, Biotech, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry, Time Warner, Media, Computers, Telecom, Time Warner Telecom

Business Journal

Mylan profit down as expenses rise

Mylan Inc.'s profit dropped in the second quarter as expenses rose despite an 8 percent jump in revenue, and the company narrowed its earnings and revenue guidance for the full year.

Comment?

Related Topix: Biotech, Startups, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry

Wed Aug 06, 2014

Seeking Alpha

Mylan's Inversion Passes Taxes On To Shareholders - Here's What You Should Know

Mylan has gathered a few headlines lately for their inversion with Abbott Laboratories .

Comment?

Related Topix: Biotech, Startups, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry, Abbott Laboratories

Tue Aug 05, 2014

Seeking Alpha

Mylan: Buy, Sell, Or Hold

With a PEG close to 1.0 and a discounted earnings model that shows Mylan to be fairly valued, I consider the stock a hold at this point.

Comment?

Related Topix: Biotech, Medicine, Pharmaceuticals, Healthcare Industry, Startups, Mylan Laboratories, Teva Pharmaceutical Industries, Financial Markets

Sun Aug 03, 2014

Post-gazette.com

Laws, loopholes can test private, public ties

Just ask Sen. Joe Manchin, D-W.Va., who opposes corporate tax inversions even as Mylan, the pharmaceutical company where his daughter Heather Bresch is CEO, is using them to lessen its tax burden.

Comment?

Related Topix: Startups, US News, US Senate, Democrat, Biotech, US Politics, Senator Joe Manchin, Medicine, Pharmaceuticals, Mylan Laboratories, Healthcare Industry, US Governors, Joe Manchin, US House of Representatives, John Dingell

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••